Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 19, Issue SUPPL. 2, 2008, Pages

  Briasoulis, E ^a,c   Pavlidis, N ^b,c   Felip, E ^b,c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PLATINUM;

ARTICLE; BLOOD EXAMINATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER OF UNKNOWN PRIMARY SITE; CANCER STAGING; CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; ENDOSCOPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL SOCIETY; OCCULT BLOOD TEST; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY; TREATMENT PLANNING; URINALYSIS; INCIDENCE; PATHOLOGY;

FOLLOW-UP STUDIES; HUMANS; INCIDENCE; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY;

EID: 45149093802     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn104     Document Type: Article

References (6)

1. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003; 39: 1990-2005.
2. Abbruzzese JL, Abbruzzese MC, Lenzi R et al. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13: 2094-2103.
3. Culine S, Kramar A, Saghatchian M et al. Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 2002; 20: 4679-4683.
4. Armstrong AC, Blackhall FH. Management of cancer from an unknown primary. Expert Opin Pharmacother 2007; 8: 445-455.
5. Seve P, Billotey C, Broussolle C et al. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer 2007; 109: 292-299.
6. Pavlidis N. Forty years experience of treating cancer of unknown primary. Acta Oncol 2007; 46: 592-601.